On July 28, the 2026 H1 Business Exchange Meeting was successfully held between Health Technology and Jointown Pharmaceutical Group. Liu Yichang, Vice Chairman and Business President of Jointown, led a delegation for the visit and exchange. Li Shuxiang, Deputy Secretary of the Party Committee and General Manager of Tianjin Pharmaceutical Co., Ltd., headed the reception team, with relevant business principals from both sides in attendance.

The meeting comprehensively reviewed the progress of sales cooperation, analyzed the current market situation, and jointly discussed key work priorities for the second half of the year.

During the meeting, participants conducted in-depth exchanges on market development trends and business collaboration advancement, and explored future cooperation ideas, laying a solid foundation for further in-depth cooperation. Based on the prevailing market conditions and business development needs, the two parties held thorough discussions and reached extensive consensus on deepening channel collaboration, strengthening resource sharing, improving market operation efficiency, and driving the development of key products.

Both sides stated that they will further leverage their respective advantages, strengthen business linkage and information communication, continuously expand cooperation boundaries, improve cooperation quality and efficiency, and jointly elevate bilateral cooperation to a higher level and broader scope.

During the visit, the Jointown delegation toured the corporate exhibition hall and intelligent command center, gaining a deeper understanding of the company’s development history, industrial layout and digital operation achievements. This exchange has further enhanced mutual trust between the two parties. Moving forward, both sides will continue to strengthen collaborative linkage to deliver more practical cooperation outcomes.

Source: Health Technology